Tetracycline-based MMP inhibitors (Tetragenex/Yuansci)

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameTetracycline-based MMP inhibitors (Tetragenex/Yuansci)
Drug Alias Namematrix metalloproteinase inhibitors (Innapharma)matrix metalloproteinase inhibitors (Tetragenex)MMP inhibitors (Innapharma)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsArthritis, RheumatoidNeoplasmsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesInnapharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnapharma IncYuanSci Bio-Tech (Tianjin) Co LtdTetragenex
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidNeoplasmsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A